Quel est le prix pour Steep Hill Inc. (STPH)

Le prix pour Steep Hill Inc. (STPH) est $0.23955051

Quelle est la capitalisation boursière pour Steep Hill Inc. (STPH)

La capitalisation boursière pour Steep Hill Inc. (STPH) est $645.93K

Revenus de Steep Hill Inc. (STPH)

Established in Toronto, Canada, in 2008, Steep Hill Inc. operates as a leading science and technology firm dedicated to the cannabis sector. The company delivers an extensive range of services throughout Canada and the United States, including sophisticated laboratory analysis, thorough quality assurance, and insightful data analytics. Its testing capabilities cover a broad spectrum, assessing cannabinoids, terpenes, pesticides, mycotoxins, heavy metals, and residual solvents. Additionally, Steep Hill conducts microbial examinations, foreign material screenings, and evaluates moisture levels, water activity, vitamin E acetate presence, and product uniformity, alongside comprehensive hemp assessments. Beyond its testing facilities, the organization offers specialized consulting regarding analytical methodologies, cannabis industry regulations, specific testing protocols, laboratory information management systems (LIMS), and overarching product integrity and safety. The entity rebranded to Steep Hill Inc. in February 2022, having previously operated as Cannabis Clonal Corporation.

Année	Revenus	Changez
Pas assez de données pour les dates fournies.

Année

Revenus

Changez

Pas assez de données pour les dates fournies.

Entreprise	Revenus	Différence de revenus	Pays
MERCK Kommanditgesellschaft auf Aktien MER.SW	-	-	DE
Merck KGaA MRK.DE	-	-	DE
Takeda Pharmaceutical Company Limited 4502.T	-	-	JP
Galderma Group AG GALD.SW	-	-	CH
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	$6.61B	-	IN

Entreprise

Revenus

Différence de revenus

Pays